News related to Zetia (Ezetimibe) and/or conditions it is approved for
Doctors gird for patient anxiety over Zetia data (Reuters)
Source: Y! Health Anxiety News [2009.11.16]
Reuters - The good news for Merck & Co's Zetia cholesterol fighter is that doctors do not seem unduly concerned about its latest setback in a clinical trial. The bad news is they think patient anxiety will cause its sales to drop anyway.
Study Raises New Questions About Cholesterol Drug Zetia (HealthDay)
Source: Y! Health Cholesterol News [2009.11.16]
HealthDay - SUNDAY, Nov. 15 (HealthDay News) -- A new study raises more
questions about ezetimibe (Zetia), a drug used by millions of Americans in
tandem with statins to lower LDL, or "bad," cholesterol.
New Study Raises New Questions About Cholesterol Drug Zetia (HealthDay)
Source: Y! Health Cholesterol News [2009.11.16]
HealthDay - SUNDAY, Nov. 15 (HealthDay News) -- A new study raises more
questions about ezetimibe (Zetia), a drug used by millions of Americans in
tandem with statins to lower LDL, or "bad," cholesterol.
New Study Raises New Questions About Cholesterol Drug Zetia
Source: MedicineNet ezetimibe Specialty [2009.11.16]
Title: New Study Raises New Questions About Cholesterol Drug Zetia
Category: Health News
Created: 11/16/2009 12:10:00 AM
Last Editorial Review: 11/16/2009
More doubts over Merck anti-cholesterol drug: study (AFP)
Source: Y! Health Cholesterol News [2009.11.16]
AFP - A new study has cast fresh doubt on the effectiveness of Zetia, a cholesterol drug produced by US pharmaceuticals giant Merck.
AHA: Niacin Bests Ezetimibe as Add-On Therapy (CME/CE)
Source: MedPage Today Neurology [2009.11.15]
ORLANDO (MedPage Today) -- In high-risk patients on long-term statin therapy, boosting HDL cholesterol with extended-release niacin (Niaspan) is a more effective way of slowing atherosclerosis than going for additional LDL cholesterol reductions by adding ezetimibe (Zetia), researchers here reported.
Ezetimibe Makes Atorvastatin More Efficient In Lowering Lipids In Men And Women Age 65 And Older
Source: Cholesterol News From Medical News Today [2009.10.29]
Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr. Christian Constance told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
ezetimibe and simvastatin, Vytorin
Source: MedicineNet ezetimibe Specialty [2008.04.16]
Title: ezetimibe and simvastatin, Vytorin
Category: Medications
Created: 1/31/2005 10:17:00 PM
Last Editorial Review: 4/16/2008
AHA: ARBITER 6-HALTS -- Are There Any Clinical Implications? (CME/CE)
Source: MedPage Today Public Health & Policy [2009.11.17]
ORLANDO (MedPage Today) -- The ARBITER 6-HALTS trial raises as many questions about using surrogate endpoints to approve drugs as it does about the efficacy of the actual drugs studied, niacin and ezetimibe.
|
